Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells

Antonella F M Dost1, Aaron L Moye1, Marall Vedaie2

  • 1Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Cell Stem Cell
|September 6, 2020
PubMed

Insights

Activating KRAS mutations in epithelial cancers cause early molecular changes. Our study used organoid models to show oncogenic KRAS reduces mature cell identity genes in lung adenocarcinoma progenitor cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutant KRAS is a key driver in many epithelial cancers.
  • Early molecular events following oncogenic KRAS activation are not well understood.
  • Understanding these early changes is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the early transcriptional consequences of oncogenic KRAS activation in epithelial cells.
  • To develop and validate organoid models for studying early-stage lung adenocarcinoma.
  • To identify molecular changes distinguishing normal progenitor cells from early cancer cells.

Main Methods:

  • Single-cell RNA sequencing to analyze transcriptional changes.
  • Comparison across four distinct sample sets: patient samples, mouse models, and two organoid systems (mouse and human iPSC-derived).
  • Development of in vitro organoid models from lung epithelial progenitor cells.

Main Results:

  • Consistent transcriptional alterations were observed across all four tested settings.
  • Alveolar epithelial progenitor (AT2) cells with oncogenic KRAS showed decreased expression of mature lineage identity genes.
  • The study generated extensive datasets and organoid tools for further research.

Conclusions:

  • In vitro organoid models are effective for studying early oncogenic KRAS effects.
  • Oncogenic KRAS activation impacts epithelial progenitor cell identity.
  • This work provides resources to identify therapeutic targets for KRAS-driven cancers.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K